Funding Will Support Development of Biomodex Products for Interventional Cardiology

 

June 7, 2018—Biomodex announced that the company has raised an additional $15 million in Series A funding that it intends to use to develop new products in the interventional cardiology space and enable the opening of a new manufacturing facility outside of Boston, Massachusetts. Biomodex is a medical device company based in Paris, France, and Boston, that uses three-dimensional (3D) printing technology to develop patient-specific synthetic organs for preoperative planning.

According to the company, Biomodex's technology enables the 3D printing of organs based on medical imaging, such as a CT scan or echocardiography. By combining 3D printing with the technology, the company is able to produce the biomechanics of the organ and surrounding tissue, mimicking the patient-specific biomechanical properties and behavior with a quick turnaround time. The solution has primarily been used for interventional neuroradiology applications.

The funding round brings total financing to more than $18.5 million. The new financing was led by Idinvest Partners and InnovAllianz with participation of pre-existing investors, LBO France and Inserm Transfert Initiative.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.